Signaling Pathways - eIF4E/eIF3G interaction - Histone Acetyltransferases (HATs) - Glutamate (Metabotropic) Group I Receptors - HCV polymerase
清除全部
- B5532 NPS 2390Target: Glutamate (Metabotropic) Group I ReceptorsSummary: I型mGlu拮抗剂
- B6569 CHPGTarget: Glutamate (Metabotropic) Group I ReceptorsSummary: mGlu5代谢型谷氨酸受体激动剂
- B3696 4EGI-12 CitationTarget: eIF4E/eIF3G interactionSummary: 竞争性的eIF4E/eIF4G相互作用抑制剂。
- A4492 NU 9056Target: Histone Acetyltransferases (HATs)Summary: KAT5(Tip60)HAT抑制剂
- A4488 Anacardic acid中文名: 漆树酸Target: Histone Acetyltransferases (HATs)Summary: HAT抑制剂
- A3738 PSI-7977中文名: 索非布韦,索氟布韦Target: HCV polymeraseSummary: 慢性丙型肝炎病毒(HCV)感染的抗病毒剂
- A3633 MPEP HydrochlorideTarget: Glutamate (Metabotropic) Group I ReceptorsSummary: MGlu5受体拮抗剂
- A3335 Curcumin1 Citation中文名: 姜黄素Target: Histone Deacetylases (HDACs)|Nrf2|Histone Acetyltransferases (HATs)|TyrosinasesSummary: Tyrosinase(酪氨酸酶)抑制剂
- A4032 VX-222 (VCH-222, Lomibuvir)Target: HCV polymeraseSummary: HCV RNA聚合酶抑制剂
- A8189 PSI-62063 CitationTarget: HCV polymeraseSummary: HCV RNA聚合酶抑制剂